Biobot Analytics is a wastewater epidemiology company that is transforming wastewater infrastructure into public health observatories. Its wastewater monitoring technology analyzes urine and stool samples to create a health database that is independent from hospital reporting systems, free from societal biases affecting who can and can't seek care, and most importantly, rapidly adaptable to new and emerging public health threats.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/21/20 | $4,200,000 | Seed |
AmFam Institute Impact Fund DCVC The Engine  Y Combinator | undisclosed |
